STOCK TITAN

T. Rowe Price (QDEL) holds 5.63M shares, reports 8.3% ownership

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G disclosing beneficial ownership of 5,629,965 shares of QuidelOrtho Corp common stock, equal to 8.3% of the class. The filing lists 5,612,705 shares with sole voting power and 5,629,965 shares with sole dispositive power. The amendment is signed by a Vice President and dated 04/08/2026.

Positive

  • None.

Negative

  • None.

Insights

Large passive holding disclosed: T. Rowe Price holds 8.3% of QuidelOrtho.

T. Rowe Price reports 5,629,965 shares beneficially owned with sole dispositive control, representing 8.3% of the class. Such Schedule 13G/A amendments typically update position counts and ownership percentages rather than signal trading intent.

Track subsequent amendments or Form 13D filings for changes in intent; investor filings and corporate disclosures will show material shifts in ownership or voting plans.

Beneficial ownership 5,629,965 shares Amount beneficially owned reported in Item 4
Percent of class 8.3% Percent of class reported in Item 4
Sole voting power 5,612,705 shares Sole power to vote reported in Item 4(i)
Sole dispositive power 5,629,965 shares Sole power to dispose reported in Item 4(iii)
Filing type Schedule 13G/A Form type provided in metadata
Signature date 04/08/2026 Signature date on the amendment
Schedule 13G/A regulatory
"Amendment No. 5 ) QUIDELORTHO CORP COMMON STOCK"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficial ownership financial
"Amount beneficially owned: 5629965 (b) | Percent of class: 8.3 %"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole dispositive power legal
"Sole power to dispose or to direct the disposition of: 5629965"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
sole voting power legal
"Sole power to vote or to direct the vote: 5612705"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does T. Rowe Price report in QDEL?

T. Rowe Price reports beneficial ownership of 5,629,965 shares, equal to 8.3% of QuidelOrtho’s common stock. The filing lists sole voting power for 5,612,705 shares and sole dispositive power for 5,629,965 shares.

Is this a Schedule 13G or 13D filing for QDEL?

This is an amended Schedule 13G/A for QDEL, used by passive institutional investors to report holdings. It updates previously reported beneficial ownership and related voting/dispositive power details.

Does T. Rowe Price claim beneficial ownership in the filing for QDEL?

The filing lists the shares as beneficially owned but includes a statement denying beneficial ownership. The filer nevertheless reports voting and dispositive powers and the 5,629,965-share position.

When was the Schedule 13G/A signed for QuidelOrtho (QDEL)?

The Schedule 13G/A amendment is signed by Ellen York, Vice President, with a signature date of 04/08/2026. The cover shows an as-of reporting date of 03/31/2026.





219798105

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:04/08/2026